Last updated on June 2016

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth


Brief description of study

A study to investigate clinical safety and effect on hair growth of FOL-005 in healthy volunteers. The study is divided in two parts, a single ascending dose (SAD) part and a multiple dose (MD) part.

Detailed Study Description

SAD part: A total of 3 weeks dosing, the two lowest concentrations in week 1, dose 3 at week 2 and finally dose 4 at week 3. MD part: In total 12 weeks of dosing where group A will be dosed twice weekly and group B three times weekly Each injection will be administered into one of five of the six randomized areas (10 cm apart, left and right side) from the subject's defined investigational skin areas. One area will be completely untreated.

Clinical Study Identifier: NCT02793557

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ulrike Blume-Peytavi, Professor

Klinik f r Dermatologie, Venerologie und Allergologie, Charit -Universit tsmedizin
Berlin, Germany
  Connect »